Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis
about
Polysaccharide nanosystems for future progress in cardiovascular pathologiesNanotechnology in diagnosis and treatment of coronary artery disease.In silico design of anti-atherogenic biomaterials.Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis.Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.Delivery of Polymeric Nanoparticles to Target Vascular Diseases.Cytokines: roles in atherosclerosis disease progression and potential therapeutic targetsNanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.Plasmonic photothermal therapy for atheroregression below Glagov threshold.Ginkgo suppresses atherosclerosis through downregulating the expression of connexin 43 in rabbits.The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.Destination Known: Targeted Drug Delivery in Atherosclerosis and ThrombosisMedical Applications of Iron Oxide NanoparticlesMicrofluidic Platforms for Evaluation of Nanobiomaterials: A Review
P2860
Q27025494-59984E61-6A09-4F77-BBB0-9EE6859665A2Q30362371-92555E89-8AD5-44D1-99CB-CAEDD5131BCFQ34869890-256F8AAC-F943-470E-B477-E9C3FA48460EQ35108987-05FCA7C4-0B9C-4935-B70B-42AD11C40421Q35157103-C69B7FD0-E3AE-4A56-BF40-EB5F3043F928Q35701214-FAD084C8-3909-4252-8684-307A3ADF1034Q36064353-CBC7C122-58CE-4FAC-B91F-C4C0C1555F65Q36496336-45F45B8B-C1AF-4692-A1EC-702DAA60DB58Q36596084-BC36B9B9-687A-4C59-AEED-C2887429B562Q36598388-C2432BCB-A07F-4131-AED0-DA3B4103B6B4Q36913594-D79AC4B7-F95F-45E8-AFB2-E7FB9C3DE368Q38027231-3DC84016-DA1D-4B02-8CC3-ED39F0A1255BQ38106503-1EDC7205-81B2-403D-B980-CF19394B4CBBQ40549729-3F08AEA2-9E24-4B00-B1CB-BCE1D6E635C5Q54402965-AF7AEC2D-AC5E-4D43-85B2-7755A9A1EDE7Q57342839-8D523FF4-1686-4157-ACCB-58CD9FBF9D78Q57559237-112DC263-1BE9-424C-9E51-3021B8BD1157Q58910627-70B48182-CB15-4A61-BEBB-D5056BBE293F
P2860
Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Polymer-based therapeutics: na ...... management of atherosclerosis
@ast
Polymer-based therapeutics: na ...... management of atherosclerosis
@en
type
label
Polymer-based therapeutics: na ...... management of atherosclerosis
@ast
Polymer-based therapeutics: na ...... management of atherosclerosis
@en
prefLabel
Polymer-based therapeutics: na ...... management of atherosclerosis
@ast
Polymer-based therapeutics: na ...... management of atherosclerosis
@en
P2093
P2860
P356
P1476
Polymer-based therapeutics: na ...... management of atherosclerosis
@en
P2093
Adam W York
Daniel R Lewis
Kubra Kamisoglu
Prabhas V Moghe
P2860
P304
P356
10.1002/WNAN.145
P577
2011-04-26T00:00:00Z